Mentice expands Coronary Product Portfolio with the introduction of Coronary Intermediate software
Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio. Coronary Intermediate follows the introduction of Coronary Essentials three months earlier at the 20th International Meeting on Simulation in Healthcare (IMSH 2020). Designed by clinical experts, the software helps improve user proficiency by incorporating an extensive library of cases that present various degrees of difficulty. To better handle complexities encountered with real patients, the